| Not Yet Recruiting | CAN1012 in Pre-Malignant DCIS and LCIS Ductal Carcinoma in Situ, Lobular Carcinoma in Situ | Phase 1 | 2026-05-01 |
| Recruiting | A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combin Advanced Solid Tumors | Phase 1 | 2025-06-17 |
| Recruiting | Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients Triple Negative Breast Cancer | Phase 2 | 2024-09-05 |
| Recruiting | Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complet Primary Central Nervous System Lymphoma | Phase 2 | 2024-03-13 |
| Recruiting | GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Ne Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2024-02-29 |
| Withdrawn | GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer P Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-07-01 |
| Active Not Recruiting | Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) Malignant Epithelial Neoplasms | Phase 1 | 2023-04-03 |
| Active Not Recruiting | Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors Neuroendocrine Tumors | Phase 1 | 2022-12-28 |
| Active Not Recruiting | Clinical Outcomes and Patient Satisfaction With Use of the Amma System Breast Cancer | — | 2022-08-22 |
| Active Not Recruiting | Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma Melanoma, Uveal | Phase 2 | 2022-08-02 |
| Terminated | Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication Multiple Sclerosis | — | 2022-07-11 |
| Completed | SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer Rectal Cancer | Phase 2 | 2022-07-05 |
| Terminated | Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma Refractory Cutaneous Melanoma | Phase 2 | 2022-06-08 |
| Active Not Recruiting | Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) Malignant Epithelial Neoplasms | Phase 1 | 2022-02-08 |
| Active Not Recruiting | Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2022-01-11 |
| Withdrawn | Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Ca Breast Cancer Stage IV | Phase 1 / Phase 2 | 2021-12-15 |
| Withdrawn | Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis Relapsing Multiple Sclerosis, Multiple Sclerosis | — | 2021-10-19 |
| Active Not Recruiting | Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer Breast Cancer | Phase 1 | 2021-09-10 |
| Recruiting | Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy Cancer of the Head and Neck | Phase 1 | 2021-08-05 |
| Terminated | CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) SARS-CoV-2 | Phase 1 | 2020-12-30 |
| Active Not Recruiting | Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer Breast Cancer, Breast Neoplasms | Phase 2 | 2020-12-30 |
| Active Not Recruiting | Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refract BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma | Phase 2 | 2020-10-30 |
| Completed | A Systems Approach to Understanding Disease Processes in Multiple Sclerosis Multiple Sclerosis | — | 2020-05-11 |
| Suspended | Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care COVID-19, Corona Virus Infection, SARS-CoV-2 | Phase 4 | 2020-03-30 |
| Completed | Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocre Multiple Sclerosis, Infusion Reaction | Phase 3 | 2020-02-05 |
| Terminated | Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM Glioblastoma, Cancer of Brain, Glioblastoma Multiforme | Phase 1 | 2019-12-02 |
| Active Not Recruiting | Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patien Breast Neoplasm Female, Breast Cancer, Breast Carcinoma | Phase 2 | 2019-04-03 |
| Active Not Recruiting | Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Melanoma | Phase 1 | 2018-07-25 |
| Completed | Melatonin in Patients With Multiple Sclerosis (MS). Relapsing Remitting Multiple Sclerosis | EARLY_Phase 1 | 2018-05-09 |
| Active Not Recruiting | Neoadjuvant Immunoradiotherapy in Head & Neck Cancer Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2018-01-15 |
| Unknown | Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients Breast Cancer | N/A | 2017-08-24 |
| Completed | Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab Relapsing Remitting Multiple Sclerosis | — | 2017-06-01 |
| Completed | Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) Breast Neoplasm, Breast Neoplasm, Male, Triple Negative Breast Cancer | Phase 1 | 2017-02-09 |
| Completed | Pathogen Detection and Community Acquired Pneumonia Community Acquired Pneumonia | N/A | 2017-01-01 |
| Active Not Recruiting | Ipilimumab for Head and Neck Cancer Patients Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2016-11-18 |
| Completed | GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Pa Melanoma, Non-Small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2016-05-16 |
| Active Not Recruiting | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer Rectal Adenocarcinoma | Phase 2 | 2016-03-24 |
| Terminated | Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer Colorectal Neoplasms | Phase 1 | 2016-03-14 |
| Active Not Recruiting | Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2016-02-23 |
| Completed | Achieving the Quadruple Aim by Reducing Burnout Burnout, Professional | N/A | 2016-01-01 |
| Active Not Recruiting | MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2015-07-20 |
| Completed | ACTH for Fatigue in Multiple Sclerosis Patients Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2015-05-22 |
| Unknown | Caring for the Whole Person Behavioral Health | — | 2015-03-01 |
| Active Not Recruiting | Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Ren Renal Cell Carcinoma | Phase 2 | 2014-12-01 |
| Unknown | Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients Breast Cancer | N/A | 2014-12-01 |
| Completed | Anti-OX40 Antibody in Head and Neck Cancer Patients Head and Neck Cancer | Phase 1 | 2014-11-12 |
| Completed | α-TEA in Advanced Cancer Metastatic Carcinoma, Metastatic Sarcoma, Metastatic Lymphoma | Phase 1 | 2014-08-04 |
| Completed | Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma Metastatic Melanoma | Phase 1 | 2014-05-08 |
| Completed | Telemedicine Technology Demonstration Project for Heart Failure Heart Failure | N/A | 2014-03-23 |
| Completed | Immunoscore in Rectal Cancer Cancer of the Rectum, Neoplasms, Rectal, Rectal Cancer | — | 2014-01-24 |
| Completed | Phase I Study of Safety and Immunogenicity of ADU-623 Astrocytic Tumors, Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | 2014-01-08 |
| Completed | MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV Multiple Sclerosis | Phase 4 | 2013-10-01 |
| Completed | Measurement of Relaxin Peptide in Multiple Sclerosis (MS) Multiple Sclerosis, Relapsing-Remitting | — | 2013-09-20 |
| Completed | Chemoimmunotherapy and Radiation in Pancreatic Cancer Locally Advanced Malignant Neoplasm | Phase 1 | 2013-07-01 |
| Completed | Vaginal Delivery Debrief Checklist to Improve Team Communication Other Specified Complications of Labor and Delivery | N/A | 2013-05-12 |
| Withdrawn | Comparison Study of Insulin Glargine and NPH Insulin Diabetes | Phase 4 | 2013-04-01 |
| Terminated | Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patien Heart Failure | N/A | 2013-01-01 |
| Withdrawn | Study of Immune Responses in Patients With Metastatic Melanoma Metastatic Melanoma | Phase 2 | 2012-09-01 |
| Completed | Prevalence, Awareness and Management of Hypertension in Acute Care Personnel Hypertension | N/A | 2012-08-01 |
| Terminated | Multi-Drug Desensitization Protocol for Heart Transplant Candidates Heart Transplantation | Phase 2 | 2012-07-01 |
| Completed | Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastat Metastatic Breast Cancer, Lung Metastases, Liver Metastases | Phase 1 | 2012-04-27 |
| Unknown | Prospective Donor Specific Antibody (DSA) Monitoring Protocol Kidney Transplant, Kidney/Pancreas Transplant | — | 2011-08-01 |
| Active Not Recruiting | Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. Metastatic Melanoma | Phase 2 | 2011-07-01 |
| Completed | Immunochemoradiotherapy in Patients With Pancreatic Cancer Locally Advanced Pancreatic Adenocarcinoma | Phase 1 | 2011-01-01 |
| Completed | Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Metastatic Prostate Cancer, Cancer of the Prostate, Prostate Cancer | Phase 1 | 2010-10-14 |
| Terminated | Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Non-squamous Non-small Cell Lung Cancer | Phase 2 | 2010-02-01 |
| Terminated | The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer Esophagitis | Phase 1 / Phase 2 | 2009-10-01 |
| Terminated | Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts Fatigue, Sleep Deprivation, Depression | N/A | 2009-10-01 |
| Terminated | The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer Mucositis | Phase 1 / Phase 2 | 2009-10-01 |
| Terminated | Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC) Melanoma | Phase 2 | 2009-07-01 |
| Completed | A Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy Cholecystectomy, Laparoscopic | Phase 3 | 2009-02-01 |
| Completed | Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 1 | 2009-01-01 |
| Completed | Work Hour Reductions, Medical Errors, and Intern Well-Being at Providence St. Vincent Medical Center Intensive Sleep Deprivation, Depression | N/A | 2008-06-01 |
| Unknown | Retrospective Study of the Impact of Drug Eluting Stents Coronary Artery Disease | — | 2007-05-01 |
| Unknown | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic Prostate Cancer | Phase 1 / Phase 2 | 2005-07-01 |
| Terminated | Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer Non-small-Cell Lung Carcinoma | Phase 2 | 2005-05-01 |
| Completed | Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2003-11-01 |
| Completed | Carotid Artery Stenting With Protection Registry Carotid Artery Stenosis | Phase 3 | 2003-09-01 |
| Completed | Angiotensin II Antagonism of TGF-Beta 1 Diabetic Nephropathy, Hypertension | N/A | 2002-08-01 |
| Completed | The Heart Institute of Spokane Diet Study Myocardial Infarction | Phase 3 | 2000-10-01 |
| Completed | Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation Transplant Bone Disease | N/A | 1999-01-01 |
| Temporarily Not Available | Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors KRAS G12V Mutant Advanced Epithelial Cancers | — | — |